Combination Antiretroviral Therapy Is Associated With Weight Gain, Especially After 2 Years of Treatment
To explore factors associated with gaining weight in patients with HIV receiving ART, the researchers retrospectively studied a cohort of 870 adult patients with HIV who were seen for at least 3 months at the Wexner Medical Center Infectious Diseases Clinic.
Health system researchers compared patient characteristics between influenza vaccine recipients and non‑recipients as recorded in their electronic medical records from October 2020 through March 2021.
In this podcast, Titilola Labisi, MHA, MPH, speaks about factors associated with lack of viral suppression among women living with HIV in the United States, including keys to preventing sexual transmission, risk of drug resistance, and improving health outcomes for women living with HIV. She also presented a poster abstract on this topic at ID Week 2021.
Eugenia L. Siegler, MD, answers our questions about her approach to managing older adults with HIV, the challenges she and the older population face, and how to overcome those challenges.
Social media is a powerful tool in today’s society and is an important platform for health care providers and organizations to spread positive messages to their patients, their patients’ guardians, and the public. Jennifer A. Manganello, PhD, MPH, answers our questions about child injury prevention messages on social media.
In this podcast, Dr Ajayi discusses her team's latest research that explored the rate of acceptance of the influenza vaccine among patients with limited English proficiency, as well as how she plans to use these findings to better understand why patients refuse the vaccine.
In this podcast, Daniel Lee, MD, answers our questions about dealing with weight gain in patients with HIV, a topic he presented at the ACT HIV 2021 Conference.
In this podcast, Vinay Pathak, PhD, discusses the implications of his research presented in the session “Live-Cell Imaging of HIV-1 Nuclear Import, Uncoating, and Proviruses” at the Conference on Retroviruses and Opportunistic Infections 2021.
In this video, Steven Grinspoon, MD, talks about the overall take-home messages from his session Mechanisms and Treatments for Steatosis in HIV, including what's next for research on this topic.
In this video, Steven Grinspoon, MD, talks about why treatments for steatosis in HIV are important to study, including some reasons why most studies in nonalcoholic fatty liver disease (NAFLD) do not include patients with HIV.